Feeds › Capitol Hires
Capitol Hires
Lobbyists whose filings say they once worked in a member of Congress' office, on a committee or in the executive branch, with the public company that hired them.
About this data
- What it is
- Capitol Hires lists lobbyists who say, in a filing under the Lobbying Disclosure Act, that they once held a government job: in a member of Congress’ office, on a congressional committee or in the executive branch. Each row names the public company that hired the lobbyist (directly or through a lobbying firm), the office they came from and the job they held there.
- Who files it
- The lobbying firm (or the company, for its own lobbyists) on each quarterly report (LD-2) and registration (LD-1) it files with the Senate and the House.
- How current
- New filings are posted every day. We read each one the day after it is posted.
- Terms
- Covered positionA covered position is a job in the federal government that a lobbyist held in the 20 years before the filing: in the office of a member of Congress, on a committee, or in the executive branch. The Lobbying Disclosure Act asks the lobbyist to name it.As writtenThe office, the member and the job title are shown as the registrant typed them. A short job title such as LD or CoS is not spelled out.Linked memberA member is linked to their page only when exactly one member of Congress fits the name, the chamber, the first name and the years given. Otherwise the name is shown as written, without a link.FilingsThe same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one.
- Worth knowing
- Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The text is free-form, so we read it by rules and some offices are missed or misread. Check the filing before relying on one row. A member is linked only on a unique match, and many are not: those are shown as written. Company matching is automatic and can miss a subsidiary. Information, not investment advice.
All of this comes from lobbying disclosure filings that the Senate and the House publish.
Information, not investment advice (disclaimer). Where this data comes from.
Latest Capitol Hires
| The covered position the lobbyist says they held: an office of a member of Congress, a committee or an executive-branch body, as written in the filing. The member's name is a link only when exactly one member of Congress fits the name, chamber, first name and years given; otherwise it stays as written. | The lobbying report (LDA form LD-2) that names this lobbyist and office, with a link to it. Report period is the quarter the report covers; Posted is the day it was filed or amended, which can be much later. The same lobbyist is named again on each quarterly report for the same client, so a row is shown once, from the newest report, with the number of filings that name them. | ||||
|---|---|---|---|---|---|
| NVS Novartis AG | Raissa Downs | HHS Executive branch | Prin. Dep. Asst. Sec for Leg | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Raissa Downs | Sub Cmte on Employment Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Raissa Downs | Sen. HELP Cmte Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Jennifer Young | HHS Executive branch | Dep. Asst. Sec for Leg | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Jennifer Young | House Cmte on Ways and Means Committee | Not stated | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Jennifer Young | Sen. Cmte on Finance Committee | Not stated | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Elizabeth Murray | Steny H. Hoyer Member office · Democrat-MD | Senior Policy Advisor | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Elizabeth Murray | Mike Thompson Member office · Democrat-CA | Leg. Asst | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Elizabeth Murray | Bob Matsui (House) Member office · House | Leg. Asst | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Elizabeth Murray | Bob Graham (Senate) Member office · Senate | Leg. Asst | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Charlotte Ivancic | Jim DeMint Member office · Republican-SC | Leg. Counsel | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Charlotte Ivancic | Bill Frist Member office | Health Counsel | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Charlotte Ivancic | House Budget Cmte Committee | Counsel and Budget Analyst | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Charlotte Ivancic | John A. Boehner Member office · Republican-OH | Asst. to the Speaker for Policy | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Pamela Smith | Tom Harkin Member office · Democrat-IA | Leg. Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Pamela Smith | Sen. HELP Cmte Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Pamela Smith | Dept. of Justice Executive branch | Spec. Counsel, Ofc of Leg. Affairs | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Pamela Smith | Carol Moseley-Braun (Senate) Member office · Senate | Counsel and LA | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Emily Murry | Sub. Cmte on Helath Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Emily Murry | Ways and Means Cmte Committee | Staff Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Emily Murry | McCarthy Member office | Policy Advisor | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Emily Murry | Republicans Study Cmte Committee | Prof. Staff | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Emily Murry | Ken Calvert Member office · Republican-CA | Leg. Aide | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Emily Murry | Tom Price Member office · Republican-GA | Leg. Asst | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Margaret Joseph | House Rules Cmte Committee | CoS | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Margaret Joseph | Kyrsten Sinema Member office · Independent-AZ | CoS | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Margaret Joseph | Bobby Bright (House) Member office · House | CoS | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Margaret Joseph | Jim Matheson Member office · Democrat-UT | CoS | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Peter Fise | Sen. Cmte on Finance Committee | Health Counsel for , Health Counsel | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Peter Fise | House Cmte on Oversight & Government Reform Committee | Health Counsel for , Health Counsel | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Peter Fise | Jeanne Shaheen Member office · Democrat-NH | Health Counsel for , Health Counsel | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Parick Carroll | PSM Senate Appropriations Cmte Committee | Leg Asst | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Parick Carroll | Ray LaHood (House) Member office · House | Leg Asst | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Parick Carroll | Kevin Yoder Member office · Republican-KS | Leg Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Parick Carroll | PSM (House) Member office · House | Leg Dir | Tarplin, Downs & Young, LLC | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 8 filings |
| NVS Novartis AG | Robb Walton | Senate HELP Committee | Senior Health Policy Advisor and Counsel | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Robb Walton | Cassidy (House) Member office · House | ; Advisor | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Robb Walton | Enzi (Senate) Member office · Senate | ; Research Asst., Staff Asst., Intern on , Ranking Member | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Robb Walton | Nunes (House) Member office · House | Intern | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | John Stone | Oversight Subcommittee Committee | Counsel | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | John Stone | House E&C Cmte Committee | Senior Counsel | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | John Stone | Health Subcommittee Committee | Senior Counsel | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | John Stone | House Energy and Commerce Committee | Intern | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Daniel Farmer | Debbie Wasserman Schultz Member office · Democrat-FL | Intern, Staff Asst, Leg. Corr./Leg. Asst | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Daniel Farmer | Zack Space Member office | Leg. Asst., Sr. Leg. Asst., Leg. Dir | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Joel Bailey | Panetta (House) Member office · House | COS | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Joel Bailey | Ashford (House) Member office · House | LD | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Joel Bailey | Matheson (House) Member office · House | LD | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Joel Bailey | Matsui (House) Member office · House | Sr. LA | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
| NVS Novartis AG | Joel Bailey | Baron Hill (House) Member office · House | LA, Sr. LA | BGR Government Affairs | Report period 2026 Q3 ↗ Posted Oct 20, 2026 · in 9 filings |
The newest 50 of 147 matching. Narrow them with the filters above.
Each row reflects what was disclosed at the time of filing. A lobbyist listed may no longer be registered. The same lobbyist is usually named again on each quarterly report for the same client. A row is shown once, with the number of filings that name them for this client and the latest one. Updated Nov 15, 2026, 5:41 PM EST.